A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


December 18, 2008

Thyroid Problems More Common in HIV Population

People with HIV may have a higher than expected rate of thyroid problems, according to the authors of a study published in the January 1 issue of the Journal of Acquired Immune Deficiency Syndromes.

A small gland in the neck, the thyroid controls our body’s heat regulation, tissue development and energy and food use. People with hypothyroidism, or an underactive thyroid, may experience fatigue and weight gain, among other problems. Hyperthyroidism, or an overactive thyroid, can lead to jitteriness, weight loss and hot flashes.

Research exploring whether these problems are more likely to occur in people with HIV has been inconsistent, and as a result, it remains unclear whether screening for thyroid disorders should become a routine component of HIV care.

Mark Nelson, MA, MBBS, MRCP, from the department of HIV medicine at the Chelsea and Westminster Hospital in London, and his colleagues examined the medical records of 2,437 HIV-positive patients who’d had their thyroid function tested. Nelson and his colleagues found that 54 patients had abnormal thyroid functioning. After controlling for factors such as age and CD4 counts before starting antiretroviral (ARV) therapy, Nelson’s team found that protease inhibitors were associated with hypothyroidism. Conversely, hyperthyroidism was most often associated with non-nucleoside reverse transcriptase inhibitors (NNRTIs), especially efavirenz (found in Sustiva and Atripla).

Though the overall number of people diagnosed with a thyroid disorder was low, just 2.2 percent, the rate is higher than the authors would have expected in the general population. For this reason, they recommend that people with HIV be routinely screened for thyroid function.

Search: thyroid, hypothyroidism, hyperthyroidism, Mark Nelson, Chelsea and Westminster Hospital, protease inhibitors, NNRTIs, efavirenz, Sustiva, Atripla

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (2 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.